Clinical Trial Update: CHIlled Platelet Study "CHIPS" [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of chilled platelets for acute blood loss has completed, with the study status updated by sponsor Philip Spinella.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blood Loss

Drugs mentioned

• Chilled platelets (CHIPS) (cold-stored platelets)

Snippet

Sponsor: Philip Spinella | Conditions: Acute Blood Loss | Phase 3 | Status: COMPLETED